Geode Capital Management
AEON icon

Geode Capital Management’s AEON Biopharma AEON Stock Holding History

Geode Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.6K Buy
95,311
+8,249
+9% +$6.9K ﹤0.01% 4187
2026
Q1 		$85.8K Buy
87,062
+26,928
+45% +$30.1K ﹤0.01% 4170
2025
Q4 		$66.1K Buy
60,134
+13,061
+28% +$12.2K ﹤0.01% 4186
2025
Q3 		$38.1K Buy
47,073
+26,378
+127% +$20.3K ﹤0.01% 4347
2025
Q2 		$15.7K Buy
+20,695
New +$11.9K ﹤0.01% 4390
2025
Q1 		– Sell
-3,497
Closed -$136K – 4478
2024
Q4 		$136K Buy
3,497
+120
+4% +$6.99K ﹤0.01% 4014
2024
Q3 		$255K Buy
3,377
+782
+30% +$68.8K ﹤0.01% 3823
2024
Q2 		$196K Buy
2,595
+101
+4% +$24.1K ﹤0.01% 3916
2024
Q1 		$2.08M Buy
2,494
+102
+4% +$73.9K ﹤0.01% 3097
2023
Q4 		$1.24M Buy
2,392
+12
+0.5% +$4.82K ﹤0.01% 3266
2023
Q3 		$960K Buy
2,380
+2,175
+1,061% +$996K ﹤0.01% 3341
2023
Q2 		$107K Hold
205
– – ﹤0.01% 4312
2023
Q1 		$150K Hold
205
– – ﹤0.01% 4174
2022
Q4 		$148K Hold
205
– – ﹤0.01% 4241
2022
Q3 		$145K Buy
+205
New +$145K ﹤0.01% 4378

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management's AEON Position: Q2 2026 in Review

Geode Capital Management increased its AEON Biopharma (AEON) stake by 9.5% in Q2 2026, buying an estimated $6.9K and bringing the position to 95,311 shares worth $68.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4187.

Geode Capital Management first reported a position in AEON in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.08M in Q1 2024. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

  • Geode Capital Management held 95,311 shares of AEON Biopharma worth $68.6K as of Q2 2026.
  • Geode Capital Management bought 8,249 AEON Biopharma shares in Q2 2026, an estimated $6.9K.
  • AEON Biopharma made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4187 holding.
  • Geode Capital Management first reported a position in AEON Biopharma in Q3 2022 and has held it in 15 quarters since.
  • Geode Capital Management's AEON Biopharma position peaked at $2.08M in Q1 2024.
  • 22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.